DelveInsight’s Comprehensive Insights into Parkinson’s Disease Market Dynamics

DelveInsight’s Parkinson’s Disease Market Insights report offers a thorough understanding of current treatment practices, emerging drugs, market share of individual therapies, and the current and forecasted market size from 2019 to 2032. The report provides segmentation for 7MM (the United States, the EU-4 – Italy, Spain, France, and Germany, the United Kingdom, and Japan).

Click here to know Parkinson’s Disease Market

Key Takeaways from the Parkinson’s Disease Market Report:

  1. Parkinson’s Disease Market Size and Prevalence:
    • The Parkinson’s disease market size in the 7MM was approximately USD 3.2 billion in 2022.
    • Estimated total diagnosed prevalent Parkinson’s disease cases in the 7MM were around 2.5 million in 2022.
  2. Leading Parkinson’s Disease Companies and Drug Development:
    • Key industry leaders, including Cerevel Therapeutics, Pfizer, Pharma Two B, AbbVie, Biogen, Denali Therapeutics, and others, are actively developing novel Parkinson’s disease drugs.
    • Promising therapies in the pipeline include Tavapadon, P2B001, ABBV-951 (foscarbidopa/foslevodopa), BIIB122/DNL151, and more.
  3. Parkinson’s Disease Epidemiological Segmentation:
    • DelveInsight estimates approximately 2.5 million diagnosed prevalent cases of Parkinson’s disease in the 7MM in 2022.
    • Parkinson’s disease is identified as a male-dominant disease, with 54% of cases in males and 46% in females in the 7MM.

Click here to know Parkinson’s Disease Market

Parkinson’s Disease Overview:

Parkinson’s disease is a degenerative ailment characterized by the loss of nerve cells in the substantia nigra, a brain region governing movement. The exact cause remains unknown, but a combination of genetic and environmental factors is suspected. Motor symptoms such as bradykinesia, stiffness, rest tremor, and postural instability are common, accompanied by non-motor symptoms impacting a patient’s quality of life.

Parkinson’s Disease Epidemiological Segmentation:

The Parkinson’s disease market report offers epidemiological analysis for the study period 2019–2032, segmented into diagnosed prevalent population, gender-specific diagnosed prevalent population, age-specific diagnosed prevalent population, and stage-specific diagnosed prevalent population.

Parkinson’s Disease Treatment Landscape:

The Parkinson’s Disease treatment landscape involves various drugs, with Levodopa being the gold standard for managing motor problems. Medications such as levodopa, dopamine agonists, MAO B inhibitors, catechol o-methyltransferase inhibitors, and others aim to reduce motor symptoms. INBRIJA (levodopa) is a notable inhalation therapy supplementing daily carbidopa-levodopa medications to alleviate “off-episodes” and motor symptoms.

Pipeline Parkinson’s Disease Therapies and Key Companies:

The pipeline includes potential therapies like Tavapadon, P2B001, ABBV-951, BIIB122/DNL151, and others developed by leading companies such as Cerevel Therapeutics, Pfizer, AbbVie, Biogen, and more.

Parkinson’s Disease Market Dynamics:

The Parkinson’s disease market is anticipated to evolve, driven by research and development efforts, emerging therapies, and improvements in diagnosis rates. However, challenges such as the absence of a cure, symptomatic treatments, side effects, and undetected cases may impede growth. The robust pipeline and advancements in disease-modifying treatments offer optimism for the future.

In conclusion, DelveInsight’s Parkinson’s Disease Market Insights report provides a comprehensive understanding of the current landscape, promising therapies, and challenges, guiding stakeholders in making informed decisions.

Click here to know Parkinson’s Disease Market

Trending Reports:

Healthcare Consulting Service

DelveInsights multidimensional, purposeful, and credible pharma and medtech consulting services will aid in the acceleration of product services, including aspects such as congress intelligence, conference coverage, CI asset/indication tracking, brand presence and penetration assessment, drug therapy uptake, and diagnostic landscape assessment to overcome several market challenges.

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Contact Us:

Ankit Nigam

Assistant Manager Marketing

info@delveinsight.com

+91-9650213330

https://www.delveinsight.com/consulting/conference-coverage-services

Published by DELVEINSIGHT

DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors.

Leave a comment

Design a site like this with WordPress.com
Get started